ARTICLE | Clinical News
Autologous activated macrophages: Began Phase I trial
October 29, 2001 8:00 AM UTC
Proneuron Biotechnology Ltd., Ness-Ziona, Israel Product: Autologous activated macrophages Business: Gene/Cell therapy Therapeutic category: Cell replacement Target: Spinal cord tissue Description: Au...